Copyright
©2014 Baishideng Publishing Group Co.
World J Anesthesiol. Mar 27, 2014; 3(1): 61-70
Published online Mar 27, 2014. doi: 10.5313/wja.v3.i1.61
Published online Mar 27, 2014. doi: 10.5313/wja.v3.i1.61
Indicator | Examples |
Altering route of delivery1 | Injecting, biting, crushing, separating oral formulations |
Accessing opioids from other sources1 | Obtaining the drug from friends/relatives |
Selling/purchasing from the “street” | |
Double-doctoring | |
Altering or creating fraudulent prescriptions | |
Drug hoarding/trading | |
Multiple emergency room visits | |
Unsanctioned use | Unauthorized dose escalations |
Binge use | |
Drug seeking behavior | Repeat prescription losses1 |
Aggressive requesting of higher doses | |
Harassing staff for faxed prescriptions or “emergency” fit-in appointments | |
Manipulation of the prescribing physician | |
Claiming nothing else “works”/requesting specific opioid1 | |
Repeated withdrawal symptoms | Dysphoria, myalgias1, GI symptoms, cravings, nausea/vomiting etc. |
Co-morbid conditions | Addicted to illicit drug, alcohol, cannabis and/or sedatives/hypnotics |
Underlying mood/anxiety disorders unresponsive to treatment | |
Social irregularity | Deteriorating/poor social function |
Concern expressed by family members | |
Views on opioid medication | Sometimes acknowledges being addicted |
Strong resistance to tapering or switching opioids | |
Admits to mood-levelling effects | |
Acknowledges distressing withdrawal symptoms |
- Citation: Frankel GE, Intrater H, Doupe M, Namaka M. Opioid misuse in Canada and critical appraisal of aberrant behavior screening tools. World J Anesthesiol 2014; 3(1): 61-70
- URL: https://www.wjgnet.com/2218-6182/full/v3/i1/61.htm
- DOI: https://dx.doi.org/10.5313/wja.v3.i1.61